Washington-Although urologists were victorious in a recent courtdecision excluding lithotripsy from the Stark II rule, the U.S. Departmentof Health and Human Services said it will appeal the ruling.
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.